medline.ch Gastroenterologie Magen-Darm Funktionelle Beschwerden

	Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance. J Gastroenterol Hepatol Xu L. PMID: 42324067 [PubMed - as supplied by publisher]
	Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance. J Gastroenterol Hepatol Zhuang H. PMID: 42320976 [PubMed - as supplied by publisher]
	Constipation with bloating: a clinical approach to evaluation and management. Ann Med Cangemi DJ, Laitman AP, Faiman O, Chang BW. PMID: 42319080 [PubMed - indexed for MEDLINE]
	Artificial Intelligence Applied to the Brain-Gut Axis in Irritable Bowel Syndrome: Advancing Toward Clinical Translation. Cureus Andafa TW, Imoh EC, Adekanmbi SA. PMID: 42317952 [PubMed]
	Effectiveness of self-administered and minimal-contact psychotherapy in reducing irritable bowel syndrome symptom severity: a systematic review. Psychol Health Med Dos Santos Silva L, Faro A, Mosterd D. PMID: 42313613 [PubMed - as supplied by publisher]
	Diagnosis and management of irritable bowel syndrome. Aust Prescr Morrison S, Talley N. PMID: 42312308 [PubMed]
	Targeted antibiotic and dietary approaches in managing small intestinal bacterial overgrowth across irritable bowel syndrome subtypes. Intern Emerg Med Iftequar Y, Bajpai P, Dav R, Harshitha KS, C C, Goel R, Chimkar S, Chowdhary R. PMID: 42310284 [PubMed - as supplied by publisher]
	Prevalence and predictors of coeliac disease in patients with irritable bowel syndrome: A prospective study from Rajasthan, India. Trop Doct Mayur D, Agarwal A, Birda CL, Gogineni VC, Susngi T, Garg MK, Kumar B, Agarwal A. PMID: 42294994 [PubMed - as supplied by publisher]
	Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study. Gastroenterol Rep (Oxf) Ukashi O, Tzur M, Yablecovitch D, Lahat A, Laish I, Albshesh A, Neuman S, Selinger L, Picard O, Yavzori M, Lipov R, Fudim E, Dvir R, Lang A, Shachar E, Kopylov U, Carter D, Ben-Horin S, Engel T. PMID: 42294460 [PubMed]
	Reframing precision nutrition in irritable bowel syndrome: a mechanism-informed conceptual framework for responder prediction and clinical translation. Front Immunol Zhou Y, Li Z, Chu Y, Zhou Z, Zhang T, Yi N, Sun W, Yan J, Yan Z, Zhu A. PMID: 42292476 [PubMed - indexed for MEDLINE]
	Irritable Bowel Syndrome with Constipation: Diagnosis and Multisymptom Management Beyond Abdominal Pain and Bowel Movement Frequency: A Review. Adv Ther Shah ED, Sharma A, Curren N, Laitman AP, Staller K. PMID: 42283961 [PubMed - as supplied by publisher]
	Residential green space mitigates genetic susceptibility to incident irritable bowel syndrome in a prospective cohort of 376â€‰749 individuals. J Glob Health Kou Z, Li R, Wang J, Shao Z, Feng J, Wei M, Fu T, Chen L, Zheng G, Lin H, Liu K. PMID: 42281490 [PubMed - indexed for MEDLINE]
	Correction to 'Effects of a Personalised FODMAP Diet Versus the National Institute for Health and Care Excellence (NICE) Dietary Advice on Symptom Control in Patients With Irritable Bowel Syndrome: Randomised Clinical Trial'. Aliment Pharmacol Ther PMID: 42276969 [PubMed - as supplied by publisher]
	Outcomes for a digital prescription mobile application for adults with irritable bowel syndrome: an uncontrolled trial. BMC Gastroenterol Butt MF, Reghefaoui M, Bush D, Aliyu A, Darie AM, Mohanan A, Sibelli A, Card TR, Corsetti M. PMID: 42271261 [PubMed - as supplied by publisher]
	Acupuncture-like transcutaneous electrical nerve stimulation for patients with irritable bowel syndrome: Pilot mixed-methods study. J Bodyw Mov Ther Fang TY, Lin TT, Yang CS, Chiang HC, Liu CY, Chien CH. PMID: 42264839 [PubMed - indexed for MEDLINE]
	Correction to: Long-Term Safety of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation in the T3MPO-3 Study. Neurogastroenterol Motil PMID: 42252906 [PubMed - in process]
	Comment on "Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis". J Gastroenterol Hepatol Zhu J, Qiu X, Ma R. PMID: 42252522 [PubMed - as supplied by publisher]
	Gut microbiota signatures differentiate trajectory-defined response phenotypes and predict self-management outcomes in irritable bowel syndrome. medRxiv Chen J, Li A, Wu W, Xu W, Zhao T, Starkweather AR, Rodriguez L, Chen MH, Cong XS. PMID: 42238447 [PubMed]
	Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance. J Gastroenterol Hepatol Loh AJC, Loo QY, Ng AK, Khoo XH, Siah KT, Abdul Majid H, Mahadeva S, Chuah KH. PMID: 42235989 [PubMed - as supplied by publisher]
	Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome. Front Genet Ke H, Chen W, Zhang Q, Liu Z, Wei P, Li L, Yu H, Huang D, Lan C, Xu N, Pi L, Song K. PMID: 42232515 [PubMed]

Artikel 1 - 20 / 9555

Seite 1 von 478



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung